One of the largest specialist care operators in the UK, Voyage Care has been sold to Wren House, a global infrastructure firm in a deal rumoured to be struck at £45m EBITDA.

The firm, which has been owned by Partners Group and Duke Street since 2014, cares for individuals with a wide range of conditions in both residential and homecare environments. This firm employs over 10,000 staff and supports 3,500 people across the UK. Notably, the group sold down a proportion of its property portfolio in 2019 but still attracted strong interest.   

Oliver Harris, Founder and Chief Executive Officer of Montreux Capital Management (UK) stated: “We are encouraged to see Voyage Care transact at such a strong multiple. We feel the Active Care Group with its superior property portfolio and quality framework is now very well placed in the market when we take the asset to sale in the medium term. The transaction signals the continued interest of infrastructure buyers in the space and the strong valuations they are willing to put forward.”

Find Us

Thameside House
Hurst Road
East Molesey
KT8 9AY

T: + 44 (0) 1932 860 140
E: info@montreuxcm.com

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.

ACCEPT